Tisagenlecleucel in Adult Patients With Aggressive B-cell Non-Hodgkin Lymphoma
Summary
- Eligibility
- for people ages 18 years and up (full criteria)
- Location
- at UCLA UCSD UCSF
- Dates
- study startedestimated completion
- Principal Investigator
- by Carolyn Mulroney (ucsd)Monica Mead (ucla)Charalambos Andreadis (ucsf)
Description
Summary
Official Title
Keywords
Eligibility
Locations
Lead Scientists at UC Health
- Carolyn Mulroney (ucsd)
Co-Investigator on several clinical trials in the Blood and Marrow Transplantation Division: BMTCTN 0402, IRB # 101006, A Phase III Randomized, Multicenter Trial comparing Sirolimus/Tacrolimus with Tacrolimus/Methotrexate as a Graft-Versus-Host Disease (GVHD) Prophylaxis After HLA- Matched, Related Peripheral Blood Stem Cell transplantation. B.A. - Monica Mead (ucla)
HS Assistant Clinical Professor, Medicine. Authored (or co-authored) 5 research publications. - Charalambos Andreadis (ucsf)
Details
- Status
- accepting new patients
- Start Date
- Completion Date
- (estimated)
- Sponsor
- Novartis Pharmaceuticals
- ID
- NCT03570892
- Phase
- Phase 3
- Study Type
- Interventional
- Last Updated